Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 7, 2011; 17(29): 3441-3447
Published online Aug 7, 2011. doi: 10.3748/wjg.v17.i29.3441
Published online Aug 7, 2011. doi: 10.3748/wjg.v17.i29.3441
Table 3 Rebleeding according to endoscopic findings n (%)
| No rebleeding(n = 88) | Rebleeding(n = 13) | Total(n = 101) | P value | |
| Forrest type | 0.990 | |||
| Ia | 6 (6.8) | 1 (7.7) | 7 (6.9) | |
| Ib | 40 (45.5) | 6 (46.2) | 46 (45.5) | |
| IIa | 42 (47.7) | 6 (46.2) | 48 (47.5) | |
| Loss of stigma | 84 (95.5) | 12 (92.3) | 96 (95.0) | 0.625 |
- Citation: Choi CW, Kang DH, Kim HW, Park SB, Park KT, Kim GH, Song GA, Cho M. Somatostatin adjunctive therapy for non-variceal upper gastrointestinal rebleeding after endoscopic therapy. World J Gastroenterol 2011; 17(29): 3441-3447
- URL: https://www.wjgnet.com/1007-9327/full/v17/i29/3441.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i29.3441